Cardiology: Aspirin Resistance in Patients with Stable Coronary Artery Disease with and without a History of Myocardial Infarction

Background: Aspirin therapy is a cornerstone in the prevention of atherothrombotic events, but recurrent vascular events are estimated to occur in 8-18% of patients taking aspirin for secondary prevention after 2 years. Estimates of biologic aspirin resistance vary from 5% to 60%, depending on the a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Annals of pharmacotherapy 2007-05, Vol.41 (5), p.737-741
Hauptverfasser:	Dorsch, Michael P, Lee, Jin Sun, Lynch, Donald R, Dunn, Steven P, Rodgers, Jo E, Schwartz, Todd, Colby, Emily, Montague, Debbie, Smyth, Susan S
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!